
Oncologist

No OPD information available
Breast Cancer
Acute Pain
Autosomal Recessive Hypotrichosis
Agranulocytosis
Breast Lump
COVID-19
Diarrhea
Febrile Neutropenia
Gestational Diabetes
Mastectomy
Melanoma
Menopause
Neurotoxicity Syndromes
Peripheral Neuropathy
Severe Acute Respiratory Syndrome (SARS)
Triple-Negative Breast Cancer
Frances M. Boyle is a female healthcare provider who helps patients with various health issues like breast cancer, acute pain, and COVID-19. She also specializes in conditions such as agranulocytosis, melanoma, and menopause. Frances M. Boyle is skilled in treating patients with breast lumps, undergoing mastectomy, and dealing with neurotoxicity syndromes.
Frances M. Boyle cares for patients by listening to their concerns, explaining treatments clearly, and showing empathy. Patients trust her because she is knowledgeable, compassionate, and dedicated to their well-being. She communicates in a friendly and respectful manner, making sure patients feel comfortable and understood.
To stay updated with the latest medical knowledge, Frances M. Boyle reads research studies, attends conferences, and collaborates with other healthcare professionals. She values learning and applies new information to provide the best care for her patients. Frances M. Boyle works well with colleagues, sharing knowledge and expertise to improve patient outcomes.
Frances M. Boyle's work has positively impacted many patients' lives by providing effective treatments, support, and guidance. Her research on supporting parents after stillbirth and neonatal death has helped families cope with loss. She is also involved in a clinical trial studying a new treatment for high-risk breast cancer, aiming to improve outcomes for patients.
In summary, Frances M. Boyle is a caring and knowledgeable healthcare provider who uses her expertise to help patients with various health conditions. Patients trust her for her compassion and dedication to providing the best care possible. Through her work and research, she continues to make a positive impact on patients' lives and contribute to advancing medical knowledge in her field.
Enrollment Status: Active not recruiting
Published: March 03, 2025
Intervention Type: Drug
Study Drug:
Study Phase: Phase 3
